Bill Text: NY S02669 | 2011-2012 | General Assembly | Introduced
Bill Title: Makes various provisions regarding health insurance coverage including requiring certain policies to cover bone density measurement and other drug therapy; removes the deductible from coverage for cervical cytological screening and mammograms; extends mammogram eligibility to persons forty and over; requires prescription drug coverage to include contraceptives; requires notice of availability of obstetrical and gynecological services; requires coverage for diagnostic testing and treatment of infertility.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2011-01-28 - REFERRED TO INSURANCE [S02669 Detail]
Download: New_York-2011-S02669-Introduced.html
S T A T E O F N E W Y O R K
________________________________________________________________________
2669
2011-2012 Regular Sessions
I N S E N A T E
January 28, 2011
___________
Introduced by Sen. KRUGER -- read twice and ordered printed, and when
printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to health insurance
coverage for diagnostic testing and treatment for infertility
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
1 Section 1. Subsection (i) of section 3216 of the insurance law is
2 amended by adding a new paragraph 28 to read as follows:
3 (28) (A) EVERY POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE
4 WHICH PROVIDES MEDICAL COVERAGE THAT INCLUDES COVERAGE FOR PHYSICIAN
5 SERVICES IN A PHYSICIAN'S OFFICE AND EVERY POLICY WHICH PROVIDES MAJOR
6 MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE
7 FOR THE DIAGNOSIS AND TREATMENT OF INFERTILITY, INCLUDING, BUT NOT
8 LIMITED TO, DRUG THERAPY, ARTIFICIAL INSEMINATION, IN VITRO FERTILIZA-
9 TION, INTRACYTOPLASMIC SPERM INJECTION, GAMETE DONATION, EMBRYO
10 DONATION, ASSISTED HATCHING, UTERINE EMBRYO LAVAGE, EMBRYO TRANSFER,
11 GAMETE INTRAFALLOPIAN TUBE TRANSFER, ZYGOTE INTRAFALLOPIAN TUBE TRANS-
12 FER, LOW TUBAL OVUM TRANSFER, GAMETE PRESERVATION, EMBRYO PRESERVATION
13 AND ANY OTHER MEDICALLY OR SURGICALLY INDICATED SERVICE OR PROCEDURE
14 THAT IS USED TO TREAT INFERTILITY OR INDUCE PREGNANCY, EXCEPT THAT IF
15 THE GROUP OR ENTITY ON WHOSE BEHALF THE POLICY IS ISSUED IS, OR IS
16 CONTROLLED BY, A RELIGIOUS OR DENOMINATIONAL GROUP OR ENTITY, NOTHING IN
17 THIS SECTION SHALL REQUIRE THE POLICY TO COVER ANY DIAGNOSIS OR TREAT-
18 MENT THAT IS CONTRARY TO THE RELIGIOUS TENETS OF SUCH GROUP OR ENTITY.
19 (B) THE COVERAGE REQUIRED UNDER SUBPARAGRAPH (A) OF THIS PARAGRAPH IS
20 SUBJECT TO THE FOLLOWING CONDITIONS:
21 (I) THE TERMS OF SUCH COVERAGE, INCLUDING, BUT NOT LIMITED TO, CO-PAY-
22 MENTS, DEDUCTIBLES AND ACCESS TO OUT-OF-NETWORK PROVIDERS, SHALL BE
23 CONSISTENT WITH THE COVERAGE PROVIDED IN THE POLICY FOR THE SPECIALTY
24 TREATMENT OF ANY OTHER DISEASE.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07241-01-1
S. 2669 2
1 (II) COVERAGE FOR PROCEDURES FOR IN VITRO FERTILIZATION, INTRACYTO-
2 PLASMIC SPERM INJECTION, ASSISTED HATCHING, GAMETE DONATION, EMBRYO
3 DONATION, EMBRYO TRANSFER, GAMETE INTRAFALLOPIAN TUBE TRANSFER OR ZYGOTE
4 INTRAFALLOPIAN TUBE TRANSFER SHALL BE REQUIRED ONLY IF:
5 (A) THE COVERED INDIVIDUAL HAS BEEN UNABLE TO ATTAIN OR SUSTAIN A
6 SUCCESSFUL PREGNANCY THROUGH REASONABLE, LESS COSTLY MEDICALLY APPROPRI-
7 ATE INFERTILITY TREATMENTS FOR WHICH COVERAGE IS AVAILABLE UNDER THE
8 POLICY, PLAN OR CONTRACT;
9 (B) THE COVERED INDIVIDUAL HAS NOT UNDERGONE FOUR COMPLETED OOCYTE
10 RETRIEVALS, EACH OF WHICH HAS RESULTED IN AT LEAST ONE COMPLETED EMBRYO
11 TRANSFER, EXCEPT THAT IF A LIVE BIRTH FOLLOWS A COMPLETED OOCYTE
12 RETRIEVAL AND EMBRYO TRANSFER, THEN COVERAGE SHALL BE REQUIRED FOR TWO
13 ADDITIONAL COMPLETED OOCYTE RETRIEVALS EACH OF WHICH RESULTS IN AT LEAST
14 ONE COMPLETED EMBRYO TRANSFER; AND
15 (C) THE PROCEDURES ARE PERFORMED AT MEDICAL FACILITIES THAT CONFORM TO
16 THE AMERICAN COLLEGE OF OBSTETRIC AND GYNECOLOGY GUIDELINES FOR IN VITRO
17 FERTILIZATION CLINICS OR TO THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDI-
18 CINE MINIMAL STANDARDS FOR PROGRAMS OF IN VITRO FERTILIZATION.
19 (III) FOR PURPOSES OF THIS SECTION, "INFERTILITY" MEANS THE INABILITY
20 TO CONCEIVE AFTER ONE YEAR OF UNPROTECTED SEXUAL INTERCOURSE OR THE
21 INABILITY TO SUSTAIN A SUCCESSFUL PREGNANCY OR THE PRESENCE OF A DEMON-
22 STRATED CONDITION IN THE MALE OR FEMALE PARTNER RECOGNIZED BY A LICENSED
23 PHYSICIAN AS A CAUSE OF THE INABILITY TO CONCEIVE OR SUSTAIN A PREGNANCY
24 TO A LIVE BIRTH.
25 S 2. Subsection (k) of section 3221 of the insurance law is amended by
26 adding a new paragraph 17 to read as follows:
27 (17)(A) EVERY POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE
28 WHICH PROVIDES MEDICAL COVERAGE THAT INCLUDES COVERAGE FOR PHYSICIAN
29 SERVICES IN A PHYSICIAN'S OFFICE AND EVERY POLICY WHICH PROVIDES MAJOR
30 MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE
31 FOR THE DIAGNOSIS AND TREATMENT OF INFERTILITY, INCLUDING, BUT NOT
32 LIMITED TO, DRUG THERAPY, ARTIFICIAL INSEMINATION, IN VITRO FERTILIZA-
33 TION, INTRACYTOPLASMIC SPERM INJECTION, GAMETE DONATION, EMBRYO
34 DONATION, ASSISTED HATCHING, UTERINE EMBRYO LAVAGE, EMBRYO TRANSFER,
35 GAMETE INTRAFALLOPIAN TUBE TRANSFER, ZYGOTE INTRAFALLOPIAN TUBE TRANS-
36 FER, LOW TUBAL OVUM TRANSFER, GAMETE PRESERVATION, EMBRYO PRESERVATION
37 AND ANY OTHER MEDICALLY OR SURGICALLY INDICATED SERVICE OR PROCEDURE
38 THAT IS USED TO TREAT INFERTILITY OR INDUCE PREGNANCY, EXCEPT THAT IF
39 THE GROUP OR ENTITY ON WHOSE BEHALF THE POLICY IS ISSUED IS, OR IS
40 CONTROLLED BY, A RELIGIOUS OR DENOMINATIONAL GROUP OR ENTITY, NOTHING IN
41 THIS SECTION SHALL REQUIRE THE POLICY TO COVER ANY DIAGNOSIS OR TREAT-
42 MENT THAT IS CONTRARY TO THE RELIGIOUS TENETS OF SUCH GROUP OR ENTITY.
43 (B) THE COVERAGE REQUIRED UNDER SUBPARAGRAPH (A) OF THIS PARAGRAPH IS
44 SUBJECT TO THE FOLLOWING CONDITIONS:
45 (I) THE TERMS OF SUCH COVERAGE, INCLUDING, BUT NOT LIMITED TO, CO-PAY-
46 MENTS, DEDUCTIBLES AND ACCESS TO OUT-OF-NETWORK PROVIDERS, SHALL BE
47 CONSISTENT WITH THE COVERAGE PROVIDED IN THE POLICY FOR THE SPECIALTY
48 TREATMENT OF ANY OTHER DISEASE.
49 (II) COVERAGE FOR PROCEDURES FOR IN VITRO FERTILIZATION, INTRACYTO-
50 PLASMIC SPERM INJECTION, ASSISTED HATCHING, GAMETE DONATION, EMBRYO
51 DONATION, EMBRYO TRANSFER, GAMETE INTRAFALLOPIAN TUBE TRANSFER OR ZYGOTE
52 INTRAFALLOPIAN TUBE TRANSFER SHALL BE REQUIRED ONLY IF:
53 (A) THE COVERED INDIVIDUAL HAS BEEN UNABLE TO ATTAIN OR SUSTAIN A
54 SUCCESSFUL PREGNANCY THROUGH REASONABLE, LESS COSTLY MEDICALLY APPROPRI-
55 ATE INFERTILITY TREATMENTS FOR WHICH COVERAGE IS AVAILABLE UNDER THE
56 POLICY, PLAN OR CONTRACT;
S. 2669 3
1 (B) THE COVERED INDIVIDUAL HAS NOT UNDERGONE FOUR COMPLETED OOCYTE
2 RETRIEVALS, EACH OF WHICH HAS RESULTED IN AT LEAST ONE COMPLETED EMBRYO
3 TRANSFER, EXCEPT THAT IF A LIVE BIRTH FOLLOWS A COMPLETED OOCYTE
4 RETRIEVAL AND EMBRYO TRANSFER, THEN COVERAGE SHALL BE REQUIRED FOR TWO
5 ADDITIONAL COMPLETED OOCYTE RETRIEVALS EACH OF WHICH RESULTS IN AT LEAST
6 ONE COMPLETED EMBRYO TRANSFER; AND
7 (C) THE PROCEDURES ARE PERFORMED AT MEDICAL FACILITIES THAT CONFORM TO
8 THE AMERICAN COLLEGE OF OBSTETRIC AND GYNECOLOGY GUIDELINES FOR IN VITRO
9 FERTILIZATION CLINICS OR TO THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDI-
10 CINE MINIMAL STANDARDS FOR PROGRAMS OF IN VITRO FERTILIZATION.
11 (III) FOR PURPOSES OF THIS SECTION, "INFERTILITY" MEANS THE INABILITY
12 TO CONCEIVE AFTER ONE YEAR OF UNPROTECTED SEXUAL INTERCOURSE OR THE
13 INABILITY TO SUSTAIN A SUCCESSFUL PREGNANCY OR THE PRESENCE OF A DEMON-
14 STRATED CONDITION IN THE MALE OR FEMALE PARTNER RECOGNIZED BY A LICENSED
15 PHYSICIAN AS A CAUSE OF THE INABILITY TO CONCEIVE OR SUSTAIN A PREGNANCY
16 TO A LIVE BIRTH.
17 S 3. Section 4303 of the insurance law is amended by adding a new
18 subsection (hh) to read as follows:
19 (HH) (1) EVERY POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE
20 WHICH PROVIDES MEDICAL COVERAGE THAT INCLUDES COVERAGE FOR PHYSICIAN
21 SERVICES IN A PHYSICIAN'S OFFICE AND EVERY POLICY WHICH PROVIDES MAJOR
22 MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE
23 FOR THE DIAGNOSIS AND TREATMENT OF INFERTILITY, INCLUDING, BUT NOT
24 LIMITED TO, DRUG THERAPY, ARTIFICIAL INSEMINATION, IN VITRO FERTILIZA-
25 TION, INTRACYTOPLASMIC SPERM INJECTION, GAMETE DONATION, EMBRYO
26 DONATION, ASSISTED HATCHING, UTERINE EMBRYO LAVAGE, EMBRYO TRANSFER,
27 GAMETE INTRAFALLOPIAN TUBE TRANSFER, ZYGOTE INTRAFALLOPIAN TUBE TRANS-
28 FER, LOW TUBAL OVUM TRANSFER, GAMETE PRESERVATION, EMBRYO PRESERVATION
29 AND ANY OTHER MEDICALLY OR SURGICALLY INDICATED SERVICE OR PROCEDURE
30 THAT IS USED TO TREAT INFERTILITY OR INDUCE PREGNANCY, EXCEPT THAT IF
31 THE GROUP OR ENTITY ON WHOSE BEHALF THE POLICY ISSUED IS, OR IS
32 CONTROLLED BY, A RELIGIOUS OR DENOMINATIONAL GROUP OR ENTITY, NOTHING IN
33 THIS SECTION SHALL REQUIRE THE POLICY TO COVER ANY DIAGNOSIS OR TREAT-
34 MENT THAT IS CONTRARY TO THE RELIGIOUS TENETS OF SUCH GROUP OR ENTITY.
35 (2) THE COVERAGE REQUIRED UNDER PARAGRAPH ONE OF THIS SUBSECTION IS
36 SUBJECT TO THE FOLLOWING CONDITIONS:
37 (A) THE TERMS OF SUCH COVERAGE, INCLUDING, BUT NOT LIMITED TO, CO-PAY-
38 MENTS, DEDUCTIBLES AND ACCESS TO OUT-OF-NETWORK PROVIDERS, SHALL BE
39 CONSISTENT WITH THE COVERAGE PROVIDED IN THE POLICY FOR THE SPECIALITY
40 TREATMENT OF ANY OTHER DISEASE.
41 (B) COVERAGE FOR PROCEDURES FOR IN VITRO FERTILIZATION, INTRACYTO-
42 PLASMIC SPERM INJECTION, ASSISTED HATCHING, GAMETE DONATION, EMBRYO
43 DONATION, EMBRYO TRANSFER, GAMETE INTRAFALLOPIAN TUBE TRANSFER OR ZYGOTE
44 INTRAFALLOPIAN TUBE TRANSFER SHALL BE REQUIRED ONLY IF:
45 (I) THE COVERED INDIVIDUAL HAS BEEN UNABLE TO ATTAIN OR SUSTAIN A
46 SUCCESSFUL PREGNANCY THROUGH REASONABLE, LESS COSTLY MEDICALLY APPROPRI-
47 ATE INFERTILITY TREATMENTS FOR WHICH COVERAGE IS AVAILABLE UNDER THE
48 POLICY, PLAN OR CONTRACT;
49 (II) THE COVERED INDIVIDUAL HAS NOT UNDERGONE FOUR COMPLETED OOCYTE
50 RETRIEVALS, EACH OF WHICH HAS RESULTED IN AT LEAST ONE COMPLETED EMBRYO
51 TRANSFER, EXCEPT THAT IF A LIVE BIRTH FOLLOWS A COMPLETED OOCYTE
52 RETRIEVAL AND EMBRYO TRANSFER, THEN COVERAGE SHALL BE REQUIRED FOR TWO
53 ADDITIONAL COMPLETED OOCYTE RETRIEVALS EACH OF WHICH RESULTS IN AT LEAST
54 ONE COMPLETED EMBRYO TRANSFER; AND
55 (III) THE PROCEDURES ARE PERFORMED AT MEDICAL FACILITIES THAT CONFORM
56 TO THE AMERICAN COLLEGE OF OBSTETRIC AND GYNECOLOGY GUIDELINES FOR IN
S. 2669 4
1 VITRO FERTILIZATION CLINICS OR TO THE AMERICAN SOCIETY FOR REPRODUCTIVE
2 MEDICINE MINIMAL STANDARDS FOR PROGRAMS OF IN VITRO FERTILIZATION.
3 (C) FOR PURPOSES OF THIS SECTION, "INFERTILITY" MEAN THE INABILITY TO
4 CONCEIVE AFTER ONE YEAR OF UNPROTECTED SEXUAL INTERCOURSE OR THE INABIL-
5 ITY TO SUSTAIN A SUCCESSFUL PREGNANCY OR THE PRESENCE OF A DEMONSTRATED
6 CONDITION IN THE MALE OR FEMALE PARTNER RECOGNIZED BY A LICENSED PHYSI-
7 CIAN AS A CAUSE OF THE INABILITY TO CONCEIVE OR SUSTAIN A PREGNANCY TO A
8 LIVE BIRTH.
9 S 4. Subparagraph (B) of paragraph 11 of subsection (l) of section
10 3221 of the insurance law, as amended by chapter 554 of the laws of
11 2002, is amended to read as follows:
12 (B) Such coverage may NOT be subject to annual deductibles and coinsu-
13 rance [as may be deemed appropriate by the superintendent and as are
14 consistent with those established for other benefits within a given
15 policy].
16 S 5. The closing paragraph of paragraph 1 of subsection (p) of section
17 4303 of the insurance law, as amended by chapter 554 of the laws of
18 2002, is amended to read as follows:
19 The coverage required in this paragraph may NOT be subject to annual
20 deductibles and coinsurance [as may be deemed appropriate by the super-
21 intendent and as are consistent with those established for other bene-
22 fits within a given policy].
23 S 6. Subparagraph (C) of paragraph 14 of subsection (l) of section
24 3221 of the insurance law, as amended by chapter 554 of the laws of
25 2002, is amended to read as follows:
26 (C) Such coverage may NOT be subject to annual deductibles and coinsu-
27 rance [as may be deemed appropriate by the superintendent and as are
28 consistent with those established for other benefits within a given
29 policy].
30 S 7. Paragraph 1 of subsection (t) of section 4303 of the insurance
31 law, as amended by chapter 554 of the laws of 2002, is amended to read
32 as follows:
33 (1) A medical expense indemnity corporation, a hospital service corpo-
34 ration or a health service corporation which provides coverage for
35 hospital, surgical, or medical care shall provide coverage for an annual
36 cervical cytology screening for cervical cancer and its precursor states
37 for women aged eighteen and older. Such coverage may NOT be subject to
38 annual deductibles and coinsurance [as may be deemed appropriate by the
39 superintendent and as are consistent with those established for other
40 benefits within a given contract].
41 S 8. This act shall take effect on the first of January next succeed-
42 ing the date on which it shall have become a law and shall apply to all
43 policies issued, renewed, modified or altered on or after such effective
44 date.
